title: [Pathological and metabolic bone diseases: Clinical importance for fracture treatment].
abstract: Pathological and metabolic bone diseases are common and relevant occurrences in orthopedics and trauma surgery; however, fractures are often treated as being the illness itself and not seen as the symptom of an underlying bone disease. This is why further diagnostics and systemic treatment options are often insufficiently considered in the routine treatment of fractures. This review focuses on osteoporosis, osteopetrosis, hypophosphatasia and Paget's disease of bone.In patients with osteoporotic vertebral or proximal femur fractures, pharmaceutical treatment to prevent subsequent fractures is an integral part of fracture therapy together with surgical treatment. Osteopetrosis is caused by compromised osteoclastic bone resorption; therefore, even in the face of an elevated bone mass, vitamin D3 supplementation is crucial to avoid clinically relevant hypocalcemia. Unspecific symptoms of the musculoskeletal system, especially together with stress fractures, are typically found in patients suffering from hypophosphatasia. In these patients measurement of alkaline phosphatase shows reduced enzyme activity. Elevated levels of alkaline phosphatase are found in Paget's disease of bone where bisphosphonates are still the treatment of choice.
authors.affiliation: Klinik für Orthopädie und Unfallchirurgie, Campus Lübeck, Universitätsklinikum Schleswig-Holstein, Ratzeburger Allee 160, 23562, Lübeck, Deutschland. ralf.oheim@uksh.de.|Institut für Osteologie und Biomechanik, Universitätsklinikum Hamburg-Eppendorf, Lottestrasse 59, 22529, Hamburg, Deutschland. ralf.oheim@uksh.de.
authors.forename: R
authors.initials: R
authors.lastname: Oheim
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000150:complications* / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D050723:Fractures, Bone / Q000209:etiology* / Q000601:surgery*; D006801:Humans; D016896:Treatment Outcome
chemical_list: D050071:Bone Density Conservation Agents
keywords: Bone diseases; Hypophosphatasia; Osteopetrosis; Osteoporosis; Paget disease of bone